Despite these limitations, uricases have the potential to become a primary therapeutic option for severe and challenging cases of hyperuricemia
FIGURE 2 3.1 Brain insulin resistance Insulin resistance in the brain perpetuates neuroinflammation, tau hyperphosphorylation, and amyloid pathology in AD and is therefore a driver of neurodegenerative disease (Steen et al., 2005)
According to standard medical guidance, all treatment decisions should be made in consultation with licensed healthcare providers who have access to complete patient medical history
Seek medical advice if you experience: Persistent or worsening low mood lasting more than two weeks, particularly if accompanied by loss of interest in activities you usually enjoy, feelings of hopelessness, or thoughts of self-harm Severe anxiety or panic attacks that interfere with daily functioning Significant changes in sleep patterns , such as insomnia or excessive sleeping Marked irritability or anger that is out of character or affecting your relationships Symptoms of hypoglycaemia (shakiness, sweating, confusion, rapid heartbeat) occurring frequently, as these require medication adjustment
